Document is current
Any future updates will be listed below
-
Authors
Dai, Chang https://orcid.org/0000-0001-7971-883X
Xiao, Jun
Wang, Chenguang
Li, Wei https://orcid.org/0000-0001-9566-8764
Su, Guanfang https://orcid.org/0000-0003-4820-6537
-
Funding
Funding for this research was provided by:
National Eye Institute (R01EY027749, R24EY028764, R43EY031238, R43EY032827, R41EY027665)
- License Information
-
More Information
Article History
Received: 1 March 2022
Revised: 1 March 2022
Accepted: 28 March 2022
First Online: 8 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: WL is the shareholder of Everglades Biopharma, LLC, and LigandomicsRx, LLC. WL is an inventor of issued and pending patents. The remaining authors declare no conflict of interest.
